ARCHIVES

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

This article is from The Cancer Letter archive.

Vol. 08 No. 40 | October 15, 1982

Download PDF Visit The Full Archive

Related Articles

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983